Dietary Salt Intake and Vascular Function
1 other identifier
interventional
133
1 country
1
Brief Summary
The purpose of this study is to look at the effects of high- and low-salt diets on blood vessel function in healthy subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1 healthy
Started Mar 2005
Longer than P75 for early_phase_1 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 28, 2007
CompletedFirst Posted
Study publicly available on registry
January 10, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedAugust 29, 2013
August 1, 2013
7.7 years
December 28, 2007
August 28, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
endothelial function
one week
Study Arms (2)
High Sodium
ACTIVE COMPARATORHigh sodium
Low sodium
ACTIVE COMPARATORLow sodium
Interventions
Eligibility Criteria
You may qualify if:
- Healthy male, African-American volunteers
- years of age,
- No personal or first degree relative with hypertension or diabetes,
- Blood pressure \<130/85 mmHg and \> 90/60 at the screening visit,
- Body mass index \<30 kg/m2,
- No clinically significant abnormalities on screening tests (complete blood count, serum electrolytes, liver enzymes, thyroid stimulating hormone, urinalysis and electrocardiogram).
You may not qualify if:
- Alcohol intake \>2 beverage/night,
- Smoking,
- Recreational drug use,
- Personal history of coronary disease, diabetes, hypertension, stroke, kidney disease, or illness requiring overnight hospitalization in the past 6 months,
- Prescription or herbal medication use,
- Ischemic changes on resting electrocardiogram,
- Known hypersensitivity to any of the study drugs,
- Other active medical problems detected by examination or laboratory testing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rhonda Bentley-Lewis, MD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine
Study Record Dates
First Submitted
December 28, 2007
First Posted
January 10, 2008
Study Start
March 1, 2005
Primary Completion
November 1, 2012
Study Completion
November 1, 2012
Last Updated
August 29, 2013
Record last verified: 2013-08